Unique Ingredient Identifier TUF2IVW3M2 is listed as a ingredient substance
RN | 691397-13-4 |
NCIT | C84071 |
RXCUI | 155155 |
MF | Polymer substance not supported |
UNII TUF2IVW3M2 POLOXAMER 407 is commonly included in medications in the following forms.
Route | Dosage Form | Potency |
---|---|---|
INTRATYMPANIC | SUSPENSION | 15.1 %W/W |
OPHTHALMIC | SOLUTION | 0.2 % |
OPHTHALMIC | SUSPENSION, DROPS | 0.1 % |
ORAL | CAPSULE | 30 MG |
ORAL | CAPSULE (IMMED./COMP. RELEASE) | 1 MG |
ORAL | CAPSULE, DELAYED ACTION | 40 MG |
ORAL | CAPSULE, ENTERIC COATED PELLETS | 5 MG |
ORAL | CAPSULE, EXTENDED RELEASE | 8.96 MG |
ORAL | POWDER, FOR ORAL SUSPENSION | 126 MG/25.169GM |
ORAL | SOLUTION | 50 MG/5ML |
ORAL | SUSPENSION | 2.5 MG/5ML |
ORAL | TABLET | 110 MG |
ORAL | TABLET, FILM COATED | 106.7 MG |
PERIODONTAL | GEL | 15.5 % |
TOPICAL | EMULSION, CREAM | 1 %W/W |
TOPICAL | GEL | 0.2 %W/W |
TOPICAL | LOTION | 1 %W/W |
TOPICAL | OPHTHALMIC SUSPENSION DOSAGE FORM | 0.5 %W/V |
TOPICAL | SOLUTION | 0.2 %W/W |
TOPICAL | SUSPENSION, DROPS | 0.1 %W/W |